BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33988228)

  • 1. Construction of a prognostic model for non-small-cell lung cancer based on ferroptosis-related genes.
    Han K; Wang J; Qian K; Zhao T; Liu X; Zhang Y
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
    Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
    BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of non-small-cell lung cancer risk prediction model based on prognosis-associated ADME genes.
    Han K; Wang J; Qian K; Zhao T; Zhang Y
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34522968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC).
    Cui X; Liu C; Dong P; Liu C; Bai Y
    BMC Pulm Med; 2023 May; 23(1):162. PubMed ID: 37165402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
    Liu T; Luo H; Zhang J; Hu X; Zhang J
    BMC Cancer; 2021 Jul; 21(1):783. PubMed ID: 34229636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
    Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
    Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a m
    Li D; Chen T; Li QG
    BMC Pulm Med; 2023 Apr; 23(1):128. PubMed ID: 37072786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients.
    Zhang N; Wu Y; Wu Y; Wang L; Chen J; Wang X; Chard Dunmall LS; Cheng Z; Wang Y
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
    Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
    Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.
    Zhu G; Huang H; Xu S; Shi R; Gao Z; Lei X; Zhu S; Zhou N; Zu L; Mello RA; Chen J; Xu S
    Thorac Cancer; 2021 Jun; 12(12):1890-1899. PubMed ID: 33979897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
    Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
    Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer.
    Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer.
    Ding H; Shi L; Chen Z; Lu Y; Tian Z; Xiao H; Deng X; Chen P; Zhang Y
    BMC Med Genomics; 2022 Sep; 15(1):187. PubMed ID: 36056349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.